This page shows the details of why an item matched the keywords from your search.
| Item Type | Name |
|
Concept
|
Dependovirus
|
|
Concept
|
Amino Acid Sequence
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
Antibody Specificity
|
|
Concept
|
B-Lymphocytes
|
|
Concept
|
Immunoglobulin Fab Fragments
|
|
Concept
|
HIV
|
|
Concept
|
Immunoglobulin Fc Fragments
|
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
|
Concept
|
Leukocytes, Mononuclear
|
|
Concept
|
Macaca mulatta
|
|
Concept
|
Mice, Transgenic
|
|
Concept
|
HeLa Cells
|
|
Concept
|
Protein Binding
|
|
Concept
|
Cohort Studies
|
|
Concept
|
HLA-B27 Antigen
|
|
Concept
|
Humans
|
|
Concept
|
Transcription, Genetic
|
|
Concept
|
HIV Envelope Protein gp120
|
|
Concept
|
CD4-Positive T-Lymphocytes
|
|
Concept
|
Apoptosis
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
Crystallography, X-Ray
|
|
Concept
|
env Gene Products, Human Immunodeficiency Virus
|
|
Concept
|
Mice
|
|
Concept
|
Structure-Activity Relationship
|
|
Concept
|
Anti-Retroviral Agents
|
|
Concept
|
HEK293 Cells
|
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Concept
|
CTLA-4 Antigen
|
|
Concept
|
HIV Infections
|
|
Concept
|
Anti-HIV Agents
|
|
Concept
|
Antibodies, Neutralizing
|
|
Concept
|
Mice, Mutant Strains
|
|
Concept
|
HLA-B Antigens
|
|
Concept
|
HIV Antibodies
|
|
Concept
|
HIV-1
|
|
Concept
|
Mice, Inbred NOD
|
|
Academic Article
|
The Role of the Microbiome in the Etiology of Inflammatory Bowel Diseases.
|
|
Academic Article
|
Pseudo-spectral angle mapping for automated pixel-level analysis of highly multiplexed tissue image data.
|
|
Academic Article
|
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies.
|
|
Academic Article
|
Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice.
|
|
Academic Article
|
Towards HIV-1 remission: potential roles for broadly neutralizing antibodies.
|
|
Academic Article
|
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller.
|
|
Academic Article
|
Restricting HIV-1 pathways for escape using rationally designed anti-HIV-1 antibodies.
|
|
Academic Article
|
Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo.
|
|
Academic Article
|
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice.
|
|
Academic Article
|
Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission.
|
|
Academic Article
|
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice.
|
|
Academic Article
|
Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants.
|